| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. | Hepatology | 2006 | 3.46 |
| 2 | A synthetic adjuvant to enhance and expand immune responses to influenza vaccines. | PLoS One | 2010 | 1.57 |
| 3 | IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. | J Immunol | 2004 | 1.56 |
| 4 | Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. | J Leukoc Biol | 2002 | 1.55 |
| 5 | Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model. | J Transl Med | 2006 | 1.02 |
| 6 | Interleukin-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumour responses. | Immunology | 2004 | 0.88 |